Biotech Values

[pcrutch]

well I told you someone would buy $CLDA, certainly disappointed in the low ball offer though. I never had sky high expectations, but the deal doesn't respect the value of Stediavase or any other their pipeline. I had imagined a deal would be done closer to the high $30s - low $40s. I imagine Kirk et al. will have a fun time with all the lawsuits over the next month or so.